JCI vs MRKR · P/E 44, rev $23.60B vs rev $751.7K
Johnson Controls International PLC (JCI) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the JCI and MRKR stock pages for the full models.
Not investment advice.